Treatment of Rheumatoid Arthritis With Roxithromycin

A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

NCT00106548 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA)

NCT00106535 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy

NCT00106522 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis

NCT00535782 ·Status: COMPLETED ·Phase: PHASE3

A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab

NCT04115423 ·Status: UNKNOWN

A Study With Tocilizumab [RoActemra/Actemra] Monotherapy or in Combination With Methotrexate in Patients With Rheumatoid Arthritis (PICTURE)

NCT01063062 ·Status: COMPLETED ·Phase: PHASE3

A Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs or Anti-TNF

NCT01326962 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008)

NCT00542022 ·Status: COMPLETED ·Phase: PHASE2

A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

NCT01232569 ·Status: COMPLETED ·Phase: PHASE3

A Study of Tocilizumab in Patients With Rheumatoid Arthritis

NCT01187563 ·Status: COMPLETED

Real-life Experience of Tofacitinib in Patients With Treatment-Resistant Rheumatoid Arthritis

NCT04674085 ·Status: COMPLETED

Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy

NCT01362062 ·Status: COMPLETED

A Study of Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs.

NCT00996203 ·Status: COMPLETED ·Phase: PHASE4

An Extension Study of WA19926 of the Long-Term Safety of Tocilizumab (RoActemra/Actemra) in Patients With Early Moderate to Severe Rheumatoid Arthritis

NCT01664598 ·Status: COMPLETED ·Phase: PHASE3

A Study of Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

NCT01089023 ·Status: COMPLETED ·Phase: PHASE4

A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)

NCT00891020 ·Status: COMPLETED ·Phase: PHASE3

A Study of Tocilizumab (RoActemra) in Tocilizumab-Naive Participants With Rheumatoid Arthritis and Inadequate Response to Non-Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) and/or Biologic Therapy

NCT02001987 ·Status: COMPLETED ·Phase: PHASE3

A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis

NCT01941095 ·Status: COMPLETED ·Phase: PHASE3

A Long-Term Extension Study to WA19926 (NCT01007435) of Tocilizumab in Participants With Early, Moderate to Severe Rheumatoid Arthritis

NCT01665430 ·Status: TERMINATED ·Phase: PHASE3

Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis Patients

NCT01258712 ·Status: COMPLETED ·Phase: PHASE3

A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis

NCT01119859 ·Status: COMPLETED ·Phase: PHASE4

A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis

NCT00531817 ·Status: COMPLETED ·Phase: PHASE3

The Safety and Effectiveness of Tocilizumab in Rheumatoid Arthritis

NCT04384068 ·Status: UNKNOWN

A Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis

NCT05489224 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

NCT00106574 ·Status: COMPLETED ·Phase: PHASE3